These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
675 related articles for article (PubMed ID: 4047115)
21. [Amplification of the N-myc cellular oncogene in neuroblastoma. Relation to other tumor markers]. Verdona G; Garaventa A; Coviello DA; Cornaglia-Ferraris P; Tonini GP Boll Ist Sieroter Milan; 1986; 65(4):304-8. PubMed ID: 3790277 [TBL] [Abstract][Full Text] [Related]
22. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms. Martinsson T; Sjöberg RM; Hedborg F; Kogner P Cancer Res; 1995 Dec; 55(23):5681-6. PubMed ID: 7585654 [TBL] [Abstract][Full Text] [Related]
23. [Tumor cytogenetics and prognosis in neuroblastoma]. Christiansen H; Lampert F Monatsschr Kinderheilkd; 1989 Oct; 137(10):666-71. PubMed ID: 2586532 [TBL] [Abstract][Full Text] [Related]
24. [Oncogene amplification in human neuroblastomas]. Kanda N; Tsuchida Y; Hayashi Y; Ise T; Takayama J; Utakoji T Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):661-6. PubMed ID: 3963837 [TBL] [Abstract][Full Text] [Related]
25. N-myc amplification and cell proliferation rate in human neuroblastoma. Pession A; Trerè D; Perri P; Rondelli R; Montanaro L; Mantovani W; Derenzini M; Paolucci G J Pathol; 1997 Nov; 183(3):339-44. PubMed ID: 9422991 [TBL] [Abstract][Full Text] [Related]
26. Biological characteristics of N-myc amplified neuroblastoma in patients over one year of age. Nakagawara A; Ikeda K; Tsuda T; Higashi K Prog Clin Biol Res; 1988; 271():31-9. PubMed ID: 3406005 [TBL] [Abstract][Full Text] [Related]
28. Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas. Leone A; Seeger RC; Hong CM; Hu YY; Arboleda MJ; Brodeur GM; Stram D; Slamon DJ; Steeg PS Oncogene; 1993 Apr; 8(4):855-65. PubMed ID: 8384356 [TBL] [Abstract][Full Text] [Related]
29. Expression of N-myc and c-src protooncogenes correlating to the undifferentiated phenotype and prognosis of primary neuroblastomas. Matsunaga T; Takahashi H; Ohnuma N; Tanabe M; Yoshida H; Iwai J; Shirasawa H; Simizu B Cancer Res; 1991 Jun; 51(12):3148-52. PubMed ID: 2039993 [TBL] [Abstract][Full Text] [Related]
30. Expressions of N-myc and ras oncogene products in neuroblastoma and their correlations with prognosis. Nakada K; Fujioka T; Kitagawa H; Takakuwa T; Yamate N Jpn J Clin Oncol; 1993 Jun; 23(3):149-55. PubMed ID: 8350488 [TBL] [Abstract][Full Text] [Related]
31. Amplification of N-myc sequences in primary human neuroblastomas: correlation with advanced disease stage. Brodeur GM; Seeger RC; Schwab M; Varmus HE; Bishop JM Prog Clin Biol Res; 1985; 175():105-13. PubMed ID: 3991726 [No Abstract] [Full Text] [Related]
32. Inverse correlation between N-myc amplification and catecholamine metabolism in children with advanced neuroblastoma. Nakagawara A; Ikeda K; Higashi K; Sasazuki T Surgery; 1990 Jan; 107(1):43-9. PubMed ID: 2404349 [TBL] [Abstract][Full Text] [Related]
33. Antiblastic treatment does not affect N-myc gene amplification in neuroblastoma. Tonini GP; Verdona G; Garaventa A; Cornaglia-Ferraris P Anticancer Res; 1987; 7(4B):729-32. PubMed ID: 3314672 [TBL] [Abstract][Full Text] [Related]
34. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. Bown N; Cotterill S; Lastowska M; O'Neill S; Pearson AD; Plantaz D; Meddeb M; Danglot G; Brinkschmidt C; Christiansen H; Laureys G; Speleman F; Nicholson J; Bernheim A; Betts DR; Vandesompele J; Van Roy N N Engl J Med; 1999 Jun; 340(25):1954-61. PubMed ID: 10379019 [TBL] [Abstract][Full Text] [Related]
35. Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification. Raschellà G; Cesi V; Amendola R; Negroni A; Tanno B; Altavista P; Tonini GP; De Bernardi B; Calabretta B Cancer Res; 1999 Jul; 59(14):3365-8. PubMed ID: 10416595 [TBL] [Abstract][Full Text] [Related]
36. Outcome of infants with neuroblastoma detected by mass screening and surgically treated in Shiga Prefecture, Japan: what is the role of surgery? Hase T; Ohta S; Tani T; Mizukuro T; Mekata E; Naitoh H; Shimadera S; Fujino S; Taga T Pediatr Surg Int; 2002 Sep; 18(5-6):289-94. PubMed ID: 12415341 [TBL] [Abstract][Full Text] [Related]
37. N-myc oncogene and stage IV-S neuroblastoma. Preliminary observations on ten cases. Nakagawara A; Sasazuki T; Akiyama H; Kawakami K; Kuwano A; Yokoyama T; Kume K Cancer; 1990 May; 65(9):1960-7. PubMed ID: 2196987 [TBL] [Abstract][Full Text] [Related]
38. Different karyotypic patterns in early and advanced stage neuroblastomas. Kaneko Y; Kanda N; Maseki N; Sakurai M; Tsuchida Y; Takeda T; Okabe I; Sakurai M Cancer Res; 1987 Jan; 47(1):311-8. PubMed ID: 3791218 [TBL] [Abstract][Full Text] [Related]
39. Investigation of co-amplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a DEAD box gene, DDX1, with N-myc in neuroblastoma. United Kingdom Children's Cancer Study Group. George RE; Kenyon RM; McGuckin AG; Malcolm AJ; Pearson AD; Lunec J Oncogene; 1996 Apr; 12(7):1583-7. PubMed ID: 8622876 [TBL] [Abstract][Full Text] [Related]
40. Differential expression of pleiotrophin and midkine in advanced neuroblastomas. Nakagawara A; Milbrandt J; Muramatsu T; Deuel TF; Zhao H; Cnaan A; Brodeur GM Cancer Res; 1995 Apr; 55(8):1792-7. PubMed ID: 7712489 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]